{
  "hash": "afcc3433f4284f87eb77941ebcc01f1f",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Real-World Impact of Antibacterial Resistance on Mortality in Marseille (Ongoing)\"\ndescription: \"Retrospective Multi-Hospital Real-World Evidence Study (2014–2018)\"\nauthor: \"Ousmane Diallo, MPH, PhD\"\ndate: \"2025-11-11\"\nhighlight-style: pygments\npage-layout: article\nformat:\n  html:\n    css: ../assets/css/remove-keyword.css\n---\n\n\n\n::: callout-warning\n## Disclaimer – Educational Reimplementation Only\n\nThis document presents a **methodological reimplementation** of a published study on the burden of antibacterial resistance on mortality in Marseille (AP-HM, 2014–2018).\n\n-   No original **patient-level** or **confidential hospital data** are used here.\n\n-   All analyses are based on **simulated** or **anonymized / reconstructed datasets** that replicate the patterns and methodology described in the original publication.\n\n-   The aim is to demonstrate **Real-World Evidence (RWE) methods**, data engineering, and statistical modeling for my professional portfolio.\n\nThe results presented here **must not** be interpreted as official AP-HM results.\n:::\n\n# Overview\n\nThis project reproduces, using simulated or reconstructed data, the analytical pipeline of a real-world evidence (RWE) study that quantified the impact of antibacterial resistance on in-hospital mortality among patients with blood cultures in the four University Hospitals of Marseille (AP-HM) between February 2014 and February 2018\n\n::: callout-note\n## Real-world Evidence (RWE) Framing\n\n-   **Study type**: Retrospective, multi-center, observational real-world evidence study\n\n-   **Data source (conceptual)**: Routine blood culture results (MARSS surveillance system) linked with hospital mortality\n\n-   **Population**: All patients with at least one blood culture performed in AP-HM during the study period\n\n-   **Primary outcome**: In-hospital mortality\n\n-   **Key exposures**\n\n    -   Resistance to key antibiotics for top bacterial species\n    -   Difficult-to-treat resistance (DTR) phenotype\n    -   Hospital-acquired infection, ICU admission, and other clinical factors\n:::\n\n## Research Question\n\nWhat is the real-world burden of antibacterial resistance on in-hospital mortality among patients with blood cultures in a large French university hospital system?\n\n## Methods\n\n### Study Design\n\nRetrospective observational study based on routine laboratory and hospital data.\\\nPatients with at least one blood culture were followed until hospital discharge or death.\n\n### Setting\n\nFour University Hospitals of Marseille (AP-HM), France\\\nStudy period: February 2014 – February 2018.\n\n### Population\n\nAll patients with ≥1 blood culture (positive or negative).\\\nAnalyses focused on **positive cultures** involving the **10 most frequent bacterial species** in the deceased group, plus *Acinetobacter baumannii*.\n\n### Variables\n\n-   **Outcome:** In-hospital death (yes/no)\\\n-   **Key exposures:**\n    -   Resistance to key antibiotics (e.g., ceftriaxone, ciprofloxacin, imipenem, amikacin)\\\n    -   **DTR phenotype**: resistant to all first-line agents (Kadri et al. definition)\n-   **Covariates:** Age (\\>60 vs ≤60), sex, hospital-acquired infection (\\>48h after admission), ICU admission, length of stay (\\>14 days), bacterial species.\n\n### Statistical Approach\n\n-   Descriptive analysis of bacterial spectrum and resistance rates.\\\n-   Logistic regression to estimate odds ratios (ORs) for mortality associated with:\n    -   Hospital-acquired infection,\n    -   ICU admission,\n    -   DTR phenotype,\n    -   Specific bacterial species.\\\n-   All results are based on **synthetic / simulated data** emulating published patterns.\n\n------------------------------------------------------------------------\n\n## Results (Illustrative)\n\n-   Among all patients with blood cultures, those with **positive results** had nearly twice the mortality of those with negative cultures.\\\n-   The most common bacteria in both groups were *Escherichia coli*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, and *Pseudomonas aeruginosa*.\\\n-   Resistance to **ceftriaxone**, **ciprofloxacin**, and **imipenem** was more prevalent among deceased patients.\\\n-   **Hospital-acquired infection** (OR≈1.5), **ICU admission** (OR≈2.9), and **P. aeruginosa** or **E. faecium** infection (OR≈1.6–1.9) were independent mortality risk factors.\\\n-   The **DTR phenotype** was rare (≈0.3%) but significantly more frequent among deceased patients.\n\n![Fig.a Chord diagramm (deaths patients for top 20 co-infections isolated); b. Chord diagramm (survivors patients for top 20 co-infections isolated)](images/chord_diagram.png)\n\n\n\n::: {.cell}\n\n```{.r .cell-code  code-fold=\"true\" code-summary=\"Therapeutic alternatives on DTR isolates \"}\n# —— Packages\nlibrary(dplyr)\n```\n\n::: {.cell-output .cell-output-stderr}\n\n```\n\nAttaching package: 'dplyr'\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\nThe following objects are masked from 'package:stats':\n\n    filter, lag\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\nThe following objects are masked from 'package:base':\n\n    intersect, setdiff, setequal, union\n```\n\n\n:::\n\n```{.r .cell-code  code-fold=\"true\" code-summary=\"Therapeutic alternatives on DTR isolates \"}\nlibrary(tidyr)\nlibrary(plotly)\n```\n\n::: {.cell-output .cell-output-stderr}\n\n```\nLoading required package: ggplot2\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\n\nAttaching package: 'plotly'\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\nThe following object is masked from 'package:ggplot2':\n\n    last_plot\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\nThe following object is masked from 'package:stats':\n\n    filter\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr}\n\n```\nThe following object is masked from 'package:graphics':\n\n    layout\n```\n\n\n:::\n\n```{.r .cell-code  code-fold=\"true\" code-summary=\"Therapeutic alternatives on DTR isolates \"}\n# ============================================================\n# 1) DONNÉES (remplace les chiffres ci-dessous par les tiens)\n#    Utilise les mêmes libellés d'antibiotiques que dans ta figure\n#    Change \"Serie A\"/\"Serie B\" par les vraies étiquettes de légende.\n# ============================================================\n\nenterobacteria <- tibble::tribble(\n  ~antibiotic,     ~`Serie A`, ~`Serie B`,\n  \"Gentamicine\",          33,         0,\n  \"Amikacine\",            33,        75,\n  \"Tigecycline\",         100,        75,\n  \"Bactrim\",              33,         0,\n  \"Colistine\",           100,       100\n)\n\nabaumannii <- tibble::tribble(\n  ~antibiotic,     ~`Serie A`, ~`Serie B`,\n  \"Tobramycine\",         67,         0,\n  \"Amikacine\",           67,        50,\n  \"Bactrim\",             33,         0,\n  \"Colistine\",          100,       100,\n  \"Tigecycline\",        100,        67,\n  \"Rifampicine\",          0,        67\n)\n\npaeruginosa <- tibble::tribble(\n  ~antibiotic,     ~`Serie A`, ~`Serie B`,\n  \"Tobramycine\",         67,        80,\n  \"Amikacine\",           67,        85,\n  \"Colistine\",          100,       100\n)\n\n# (Option) Personnalise les noms de série ici :\nlegend_names <- c(\"Serie A\" = \"Blue series\", \"Serie B\" = \"Orange series\")\n\n# ============================================================\n# 2) FONCTION PANEL — construit un panneau barres groupées\n# ============================================================\n\npanel_bar <- function(df, panel_title, tick_angle = 0) {\n  long <- df |>\n    tidyr::pivot_longer(-antibiotic, names_to = \"series\", values_to = \"pct\") |>\n    dplyr::mutate(series = factor(series, levels = c(\"Serie A\", \"Serie B\"),\n                                  labels = legend_names[c(\"Serie A\",\"Serie B\")]))\n\n  plot_ly(long,\n          x = ~antibiotic, y = ~pct,\n          color = ~series, colors = c(\"#4E79A7\", \"#F28E2B\"),\n          type = \"bar\") |>\n    layout(\n      title = list(text = panel_title, x = 0.5),\n      barmode = \"group\",\n      bargap = 0.2,\n      xaxis = list(title = \"\", tickangle = tick_angle,\n                   categoryorder = \"array\", categoryarray = long$antibiotic),\n      yaxis = list(title = \"\", range = c(0, 120), tickmode = \"array\",\n                   tickvals = seq(0, 120, by = 20)),\n      showlegend = FALSE\n    )\n}\n\n# ============================================================\n# 3) CRÉATION DES 3 PANNEAUX\n#    (italiques via HTML <i> pour les titres d'espèces)\n# ============================================================\n\nfig1 <- panel_bar(enterobacteria, \"<b>Enterobacteria</b>\")\nfig2 <- panel_bar(abaumannii, \"<i>A. baumannii</i>\", tick_angle = 35)\nfig3 <- panel_bar(paeruginosa, \"<i>P. aeruginosa</i>\")\n\n# ============================================================\n# 4) ASSEMBLAGE EN SUBPLOT + LÉGENDE COMMUNE\n# ============================================================\n\nfig <- subplot(fig1, fig2, fig3, nrows = 3, margin = 0.06,\n               shareX = FALSE, shareY = FALSE, titleX = FALSE, titleY = FALSE) |>\n  layout(\n    legend = list(orientation = \"h\", x = 0.5, xanchor = \"center\", y = -0.08),\n    # Assure la même échelle Y sur chaque panneau\n    yaxis  = list(range = c(0,120)),\n    yaxis2 = list(range = c(0,120)),\n    yaxis3 = list(range = c(0,120))\n  )\n\nfig\n```\n\n::: {.cell-output-display}\n\n```{=html}\n<div class=\"plotly html-widget html-fill-item\" id=\"htmlwidget-c92870e72887c5f4643b\" style=\"width:100%;height:464px;\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-c92870e72887c5f4643b\">{\"x\":{\"data\":[{\"x\":[\"Gentamicine\",\"Amikacine\",\"Tigecycline\",\"Bactrim\",\"Colistine\"],\"y\":[33,33,100,33,100],\"type\":\"bar\",\"name\":\"Blue series\",\"marker\":{\"color\":\"rgba(78,121,167,1)\",\"line\":{\"color\":\"rgba(78,121,167,1)\"}},\"textfont\":{\"color\":\"rgba(78,121,167,1)\"},\"error_y\":{\"color\":\"rgba(78,121,167,1)\"},\"error_x\":{\"color\":\"rgba(78,121,167,1)\"},\"xaxis\":\"x\",\"yaxis\":\"y\",\"frame\":null},{\"x\":[\"Gentamicine\",\"Amikacine\",\"Tigecycline\",\"Bactrim\",\"Colistine\"],\"y\":[0,75,75,0,100],\"type\":\"bar\",\"name\":\"Orange series\",\"marker\":{\"color\":\"rgba(242,142,43,1)\",\"line\":{\"color\":\"rgba(242,142,43,1)\"}},\"textfont\":{\"color\":\"rgba(242,142,43,1)\"},\"error_y\":{\"color\":\"rgba(242,142,43,1)\"},\"error_x\":{\"color\":\"rgba(242,142,43,1)\"},\"xaxis\":\"x\",\"yaxis\":\"y\",\"frame\":null},{\"x\":[\"Tobramycine\",\"Amikacine\",\"Bactrim\",\"Colistine\",\"Tigecycline\",\"Rifampicine\"],\"y\":[67,67,33,100,100,0],\"type\":\"bar\",\"name\":\"Blue series\",\"marker\":{\"color\":\"rgba(78,121,167,1)\",\"line\":{\"color\":\"rgba(78,121,167,1)\"}},\"textfont\":{\"color\":\"rgba(78,121,167,1)\"},\"error_y\":{\"color\":\"rgba(78,121,167,1)\"},\"error_x\":{\"color\":\"rgba(78,121,167,1)\"},\"xaxis\":\"x2\",\"yaxis\":\"y2\",\"frame\":null},{\"x\":[\"Tobramycine\",\"Amikacine\",\"Bactrim\",\"Colistine\",\"Tigecycline\",\"Rifampicine\"],\"y\":[0,50,0,100,67,67],\"type\":\"bar\",\"name\":\"Orange series\",\"marker\":{\"color\":\"rgba(242,142,43,1)\",\"line\":{\"color\":\"rgba(242,142,43,1)\"}},\"textfont\":{\"color\":\"rgba(242,142,43,1)\"},\"error_y\":{\"color\":\"rgba(242,142,43,1)\"},\"error_x\":{\"color\":\"rgba(242,142,43,1)\"},\"xaxis\":\"x2\",\"yaxis\":\"y2\",\"frame\":null},{\"x\":[\"Tobramycine\",\"Amikacine\",\"Colistine\"],\"y\":[67,67,100],\"type\":\"bar\",\"name\":\"Blue series\",\"marker\":{\"color\":\"rgba(78,121,167,1)\",\"line\":{\"color\":\"rgba(78,121,167,1)\"}},\"textfont\":{\"color\":\"rgba(78,121,167,1)\"},\"error_y\":{\"color\":\"rgba(78,121,167,1)\"},\"error_x\":{\"color\":\"rgba(78,121,167,1)\"},\"xaxis\":\"x3\",\"yaxis\":\"y3\",\"frame\":null},{\"x\":[\"Tobramycine\",\"Amikacine\",\"Colistine\"],\"y\":[80,85,100],\"type\":\"bar\",\"name\":\"Orange series\",\"marker\":{\"color\":\"rgba(242,142,43,1)\",\"line\":{\"color\":\"rgba(242,142,43,1)\"}},\"textfont\":{\"color\":\"rgba(242,142,43,1)\"},\"error_y\":{\"color\":\"rgba(242,142,43,1)\"},\"error_x\":{\"color\":\"rgba(242,142,43,1)\"},\"xaxis\":\"x3\",\"yaxis\":\"y3\",\"frame\":null}],\"layout\":{\"xaxis\":{\"domain\":[0,1],\"automargin\":true,\"tickangle\":0,\"categoryorder\":\"array\",\"categoryarray\":[\"Gentamicine\",\"Gentamicine\",\"Amikacine\",\"Amikacine\",\"Tigecycline\",\"Tigecycline\",\"Bactrim\",\"Bactrim\",\"Colistine\",\"Colistine\"],\"type\":\"category\",\"anchor\":\"y\"},\"xaxis2\":{\"domain\":[0,1],\"automargin\":true,\"tickangle\":35,\"categoryorder\":\"array\",\"categoryarray\":[\"Tobramycine\",\"Tobramycine\",\"Amikacine\",\"Amikacine\",\"Bactrim\",\"Bactrim\",\"Colistine\",\"Colistine\",\"Tigecycline\",\"Tigecycline\",\"Rifampicine\",\"Rifampicine\"],\"type\":\"category\",\"anchor\":\"y2\"},\"xaxis3\":{\"domain\":[0,1],\"automargin\":true,\"tickangle\":0,\"categoryorder\":\"array\",\"categoryarray\":[\"Tobramycine\",\"Tobramycine\",\"Amikacine\",\"Amikacine\",\"Colistine\",\"Colistine\"],\"type\":\"category\",\"anchor\":\"y3\"},\"yaxis3\":{\"domain\":[0,0.27333333333333337],\"automargin\":true,\"range\":[0,120],\"tickmode\":\"array\",\"tickvals\":[0,20,40,60,80,100,120],\"anchor\":\"x3\"},\"yaxis2\":{\"domain\":[0.39333333333333337,0.60666666666666669],\"automargin\":true,\"range\":[0,120],\"tickmode\":\"array\",\"tickvals\":[0,20,40,60,80,100,120],\"anchor\":\"x2\"},\"yaxis\":{\"domain\":[0.72666666666666679,1],\"automargin\":true,\"range\":[0,120],\"tickmode\":\"array\",\"tickvals\":[0,20,40,60,80,100,120],\"anchor\":\"x\"},\"annotations\":[],\"shapes\":[],\"images\":[],\"margin\":{\"b\":40,\"l\":60,\"t\":25,\"r\":10},\"title\":{\"text\":\"<i>P. aeruginosa<\\/i>\",\"x\":0.5},\"barmode\":\"group\",\"bargap\":0.20000000000000001,\"showlegend\":false,\"hovermode\":\"closest\",\"legend\":{\"orientation\":\"h\",\"x\":0.5,\"xanchor\":\"center\",\"y\":-0.080000000000000002}},\"attrs\":{\"149da179e2aa\":{\"x\":{},\"y\":{},\"color\":{},\"colors\":[\"#4E79A7\",\"#F28E2B\"],\"alpha_stroke\":1,\"sizes\":[10,100],\"spans\":[1,20],\"type\":\"bar\"},\"149da691007a7\":{\"x\":{},\"y\":{},\"color\":{},\"colors\":[\"#4E79A7\",\"#F28E2B\"],\"alpha_stroke\":1,\"sizes\":[10,100],\"spans\":[1,20],\"type\":\"bar\"},\"149da1b669ad4\":{\"x\":{},\"y\":{},\"color\":{},\"colors\":[\"#4E79A7\",\"#F28E2B\"],\"alpha_stroke\":1,\"sizes\":[10,100],\"spans\":[1,20],\"type\":\"bar\"}},\"source\":\"A\",\"config\":{\"modeBarButtonsToAdd\":[\"hoverclosest\",\"hovercompare\"],\"showSendToCloud\":false},\"highlight\":{\"on\":\"plotly_click\",\"persistent\":false,\"dynamic\":false,\"selectize\":false,\"opacityDim\":0.20000000000000001,\"selected\":{\"opacity\":1},\"debounce\":0},\"subplot\":true,\"shinyEvents\":[\"plotly_hover\",\"plotly_click\",\"plotly_selected\",\"plotly_relayout\",\"plotly_brushed\",\"plotly_brushing\",\"plotly_clickannotation\",\"plotly_doubleclick\",\"plotly_deselect\",\"plotly_afterplot\",\"plotly_sunburstclick\"],\"base_url\":\"https://plot.ly\"},\"evals\":[],\"jsHooks\":[]}</script>\n```\n\n:::\n:::\n\n\n------------------------------------------------------------------------\n\n## Discussion\n\nThis real-world evidence analysis demonstrates that linking microbiology and hospital data enables quantification of the **clinical burden of antimicrobial resistance** in real practice.\\\nThe approach can inform hospital policies, identify high-risk populations, and prioritize resource allocation for antimicrobial stewardship.\n\n### RWE Value\n\n-   Demonstrates secondary use of hospital RWD for public health.\\\n-   Replicates real-world associations outside clinical trial settings.\\\n-   Highlights integration potential with HEOR studies (e.g., cost of AMR-related deaths).\n\n### Limitations\n\n-   Retrospective observational design.\\\n-   Possible misclassification of infection source.\\\n-   Analyses conducted on **synthetic / anonymized data**, not actual hospital data.\n\n------------------------------------------------------------------------\n\n## Ethics and Data Governance\n\nThis portfolio project complies with ethical standards for the use of health data:\n\n-   No identifiable or proprietary hospital data were accessed.\\\n-   All datasets were **synthetic, simulated, or anonymized**.\\\n-   The work is for **educational and methodological purposes only**.\\\n-   No institutional review board (IRB) approval was required for this reimplementation.\n\nThis ethical framework aligns with international RWE guidance (FDA, EMA) promoting transparency, data privacy, and reproducibility.\n\n------------------------------------------------------------------------\n\n## Reproducibility and Skills Demonstrated\n\n**Analytical skills illustrated in this project:** - Real-world data curation and cleaning (R, tidyverse).\\\n- Epidemiological study design and variable definition.\\\n- Logistic regression modeling of clinical outcomes.\\\n- Data visualization (R/ggplot2) and RWE storytelling.\\\n- Ethical and regulatory awareness in secondary data use.\n",
    "supporting": [
      "hospital-mortality-and-positive-blood-culture_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<link href=\"../site_libs/htmltools-fill-0.5.8.1/fill.css\" rel=\"stylesheet\" />\n<script src=\"../site_libs/htmlwidgets-1.6.4/htmlwidgets.js\"></script>\n<script src=\"../site_libs/plotly-binding-4.11.0/plotly.js\"></script>\n<script src=\"../site_libs/typedarray-0.1/typedarray.min.js\"></script>\n<script src=\"../site_libs/jquery-3.5.1/jquery.min.js\"></script>\n<link href=\"../site_libs/crosstalk-1.2.1/css/crosstalk.min.css\" rel=\"stylesheet\" />\n<script src=\"../site_libs/crosstalk-1.2.1/js/crosstalk.min.js\"></script>\n<link href=\"../site_libs/plotly-htmlwidgets-css-2.11.1/plotly-htmlwidgets.css\" rel=\"stylesheet\" />\n<script src=\"../site_libs/plotly-main-2.11.1/plotly-latest.min.js\"></script>\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}